Mrs. Melodie Jean Look, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Main St, Russell, KS 67665 Phone: 785-483-2323 Fax: 785-483-4859 |
News Archive
According to a recent study of Framingham Study participants, nearly 60 percent of people have prevalent preclinical heart failure (HF) stages A and B. Heart failure occurs when the heart muscle is weakened and cannot pump enough blood to meet the body's needs for blood and oxygen.
W. L. Gore & Associates (Gore) today announced the availability of larger sized GORE® BIO-A® Tissue Reinforcement, a valuable alternative to biologics for reinforcement of soft tissue in surgical procedures. GORE BIO-A Tissue Reinforcement is a unique non-biologic scaffold that is gradually absorbed by the body. The open, highly interconnected 3D pore structure facilitates rapid cell infiltration and vascularization.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
If you, or someone you know suffers from overactive bladder (otherwise known as OAB or "urge incontinence"), you might qualify for a research study of an approved medication where you can participate from the privacy and comfort of your own home.
Government enthusiasm for the Private Finance Initiative (PFI) in the health service - private sector investment in hospital building projects - may be dropping because of its high cost, says an editorial in this week's British Medical Journal.
› Verified 4 days ago